Advertisement
Advertisement

KMTS

KMTS logo

Kestra Medical Technologies, Ltd. Common Stock

28.35
USD
Sponsored
+1.95
+7.39%
Aug 10, 16:00 UTC -4
Closed
exchange

After-Market

28.36

+0.01
+0.04%

KMTS Earnings Reports

Positive Surprise Ratio

KMTS beat 1 of 5 last estimates.

20%

Next Report

Date of Next Report
Sep 12, 2026
Estimate for Q1 27 (Revenue/ EPS)
$29.59M
/
-$0.62
Implied change from Q4 26 (Revenue/ EPS)
+3.32%
/
-7.46%
Implied change from Q1 26 (Revenue/ EPS)
+52.75%
/
+40.91%

Kestra Medical Technologies, Ltd. Common Stock earnings per share and revenue

On Jul 14, 2026, KMTS reported earnings of -0.67 USD per share (EPS) for Q4 26, missing the estimate of -0.60 USD, resulting in a -10.27% surprise. Revenue reached 28.64 million, compared to an expected 27.01 million, with a 6.03% difference. The market reacted with a +1.80% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 9 analysts forecast an EPS of -0.62 USD, with revenue projected to reach 29.59 million USD, implying an decrease of -7.46% EPS, and increase of 3.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
-$2.10
Surprise
-3,386.38%
logo
QuidelOrtho Corporation Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
$0.13
Surprise
+374.26%
logo
CeriBell, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.48
Actual
-$0.51
Surprise
-6.10%
logo
Varex Imaging Corporation Common Stock
Report Date
Aug 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.31
Surprise
+44.93%
logo
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.03
Surprise
+74.05%
logo
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
logo
Accendra Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.19
Surprise
-113.00%
logo
Quanterix Corporation Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.45
Surprise
+4.09%
logo
Biote Corp. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.04
Actual
-$0.21
Surprise
-614.71%
logo
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
For Q4 2026, Kestra Medical Technologies, Ltd. Common Stock reported EPS of -$0.67, missing estimates by -10.27%, and revenue of $28.64M, 6.03% above expectations.
The stock price moved up 1.8%, changed from $24.18 before the earnings release to $24.61 the day after.
The next earning report is scheduled for Sep 12, 2026.
Based on 9 analysts, Kestra Medical Technologies, Ltd. Common Stock is expected to report EPS of -$0.62 and revenue of $29.59M for Q1 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement